Health and Fitness Health and Fitness
Fri, October 1, 2010
Thu, September 30, 2010
Wed, September 29, 2010
Tue, September 28, 2010
Mon, September 27, 2010
[ Mon, Sep 27th 2010 ] - Market Wire
Wellstar Announces New Website
Sun, September 26, 2010
Sat, September 25, 2010
Fri, September 24, 2010
Thu, September 23, 2010
Wed, September 22, 2010
Tue, September 21, 2010
Mon, September 20, 2010
Fri, September 17, 2010
Thu, September 16, 2010
Wed, September 15, 2010
Tue, September 14, 2010
Mon, September 13, 2010
Sun, September 12, 2010
Fri, September 10, 2010
[ Fri, Sep 10th 2010 ] - Market Wire
00 AM (ET)

Aeterna Zentaris to Present at Upcoming Sachs 10th Annual Biotech Europe Investment Forum on September 29


//health-fitness.news-articles.net/content/2010/ .. ech-europe-investment-forum-on-september-29.html
Published in Health and Fitness on Wednesday, September 22nd 2010 at 4:40 GMT by Market Wire   Print publication without navigation


QUÉBEC CITY, Sept. 22 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS,TSX: AEZ), ("the Company") a late-stage drug development company specialized in oncology and endocrinology, today announced that its President and CEO, Juergen Engel, Ph.D., will be part of the Oncology Investment panel session at the upcoming Sachs 10th Annual Biotech Europe Investment Forum on Wednesday, September 29, 2010, at 12:00 p.m. (local time), at the Radisson Blu Hotel in Zurich, Switzerland.

That same day, still as part of the Forum, Dr. Engel will also present a corporate overview at 2:15 p.m.

About Aeterna Zentaris Inc.

Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrinology. News releases and additional information are available at [ www.aezsinc.com ].


Publication Contributing Sources